Trial intelligence / Profile preview

Vaginal Seeding of the Respiratory Microbiome in C-section Infants

NCT05505110Phase 1Recruiting

Sponsor
Vanderbilt University Medical Center
Start
Nov 2022
Primary completion
Aug 2028
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in dysbiosis, sponsored by Vanderbilt University Medical Center. Primary endpoint: Feasibility of the RCT at 6 months. Started Nov 2022; status: recruiting.

02

Conditions

dysbiosis

Beyond the preview

Go deeper on NCT05505110.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05505110.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call